TABLE 74.
Reported confirmed human cases of tularaemia and notification rates per 100,000 population in EU MSs and non‐MS countries, by country and by year, 2018–2022.
| Country | 2022 | 2021 | 2020 | 2019 | 2018 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| National coverage a | Data format a | Confirmed cases and rate | Confirmed cases and rate | Confirmed cases and rate | Confirmed cases and rate | Confirmed cases and rate | ||||||
| Cases | Rate | Cases | Rate | Cases | Rate | Cases | Rate | Cases | Rate | |||
| Austria | Y | C | 35 | 0.39 | 58 | 0.65 | 33 | 0.37 | 20 | 0.23 | 7 | 0.08 |
| Belgium | Y | A | 7 | 0.06 | 9 | 0.08 | 1 | 0.01 | 4 | 0.03 | 0 | 0 |
| Bulgaria | Y | A | 1 | 0.01 | 0 | 0 | 2 | 0.03 | 1 | 0.01 | 1 | 0.01 |
| Croatia | Y | C | 1 | 0.03 | 0 | 0 | 0 | 0 | 1 | 0.02 | 0 | 0 |
| Cyprus | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Czechia | Y | C | 46 | 0.44 | 50 | 0.47 | 67 | 0.63 | 102 | 0.96 | 32 | 0.30 |
| Denmark b | – | – | – | – | – | – | – | – | – | – | – | – |
| Estonia | Y | C | 3 | 0.23 | 1 | 0.08 | 1 | 0.08 | 2 | 0.15 | 1 | 0.08 |
| Finland | Y | C | 93 | 1.7 | 86 | 1.6 | 143 | 2.6 | 48 | 0.87 | 7 | 0.13 |
| France | Y | C | 63 | 0.09 | 146 | 0.22 | 82 | 0.12 | 85 | 0.13 | 133 | 0.20 |
| Germany | Y | C | 68 | 0.08 | 113 | 0.14 | 59 | 0.07 | 70 | 0.08 | 52 | 0.06 |
| Greece | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hungary | Y | C | 9 | 0.09 | 7 | 0.07 | 20 | 0.20 | 22 | 0.23 | 17 | 0.17 |
| Ireland | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Italy | Y | C | 3 | 0.01 | 3 | 0.01 | 0 | 0 | 1 | < 0.01 | 0 | 0 |
| Latvia | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0.10 | 0 | 0 |
| Lithuania | Y | C | 15 | 0.53 | 7 | 0.25 | 2 | 0.07 | 4 | 0.14 | 5 | 0.18 |
| Luxembourg | Y | C | 0 | 0 | 3 | 0.47 | 0 | 0 | 0 | 0 | 0 | 0 |
| Malta | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Netherlands | Y | C | 1 | 0.01 | 5 | 0.03 | 1 | 0.01 | 3 | 0.02 | 2 | 0.01 |
| Poland | Y | C | 33 | 0.09 | 43 | 0.11 | 5 | 0.01 | 21 | 0.06 | 16 | 0.04 |
| Portugal | Y | C | 0 | 0 | 0 | 0 | 1 | 0.01 | 1 | 0.01 | 2 | 0.02 |
| Romania | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Slovakia | Y | C | 4 | 0.07 | 0 | 0 | 12 | 0.22 | 20 | 0.37 | 6 | 0.11 |
| Slovenia | Y | C | 12 | 0.57 | 54 | 2.6 | 1 | 0.05 | 7 | 0.34 | 4 | 0.19 |
| Spain | Y | C | 6 | 0.01 | 4 | 0.01 | 1 | < 0.01 | 88 | 0.19 | 4 | 0.01 |
| Sweden | Y | C | 220 | 2.1 | 292 | 2.8 | 247 | 2.4 | 817 | 8.0 | 102 | 1.0 |
| EU Total 27 | – | – | 620 | 0.14 | 881 | 0.20 | 678 | 0.15 | 1319 | 0.30 | 391 | 0.09 |
| United Kingdom c | – | – | – | – | – | – | – | – | 0 | 0.00 | 1 | 0.00 |
| EU Total | – | – | 620 | 0.14 | 881 | 0.20 | 678 | 0.15 | 1319 | 0.26 | 392 | 0.08 |
| Iceland | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Norway | Y | C | 58 | 1.1 | 95 | 1.8 | 99 | 1.8 | 183 | 3.4 | 58 | 1.1 |
| Liechtenstein | Y | C | 1 | 2.5 | 2 | 5.1 | 130 | 1.5 | 153 | 1.8 | 113 | 1.3 |
| Switzerland d | Y | C | 114 | 1.3 | 226 | 2.6 | ||||||
Abbreviations: –, Data not reported.
a
Y, yes; N, no; A, aggregated data; C, case‐based data.
b
No surveillance system.
c
Cases reported by the United Kingdom for the period 2018–2019 were also taken into account for this estimation (EU‐28). Data for the United Kingdom were collected for the 2018–2019 period, since it was still an EU MS at that time. However, on 1 February 2020, it became a third country.
d
Switzerland provided data directly to EFSA. The human data for Switzerland include data from Liechtenstein for the years 2018–2020.